China Animal Husbandry Industry Co Ltd
SSE:600195
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
China Animal Husbandry Industry Co Ltd
EPS (Diluted)
China Animal Husbandry Industry Co Ltd
EPS (Diluted) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
China Animal Husbandry Industry Co Ltd
SSE:600195
|
EPS (Diluted)
¥0
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-3%
|
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
EPS (Diluted)
¥0
|
CAGR 3-Years
28%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
EPS (Diluted)
¥1
|
CAGR 3-Years
25%
|
CAGR 5-Years
3%
|
CAGR 10-Years
11%
|
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
EPS (Diluted)
¥2
|
CAGR 3-Years
20%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
1%
|
|
|
Zhejiang Nhu Co Ltd
SZSE:002001
|
EPS (Diluted)
¥2
|
CAGR 3-Years
24%
|
CAGR 5-Years
6%
|
CAGR 10-Years
26%
|
|
|
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
EPS (Diluted)
¥9
|
CAGR 3-Years
N/A
|
CAGR 5-Years
241%
|
CAGR 10-Years
N/A
|
|
China Animal Husbandry Industry Co Ltd
Glance View
China Animal Husbandry Industry Co Ltd. (CAHI) is a compelling narrative of innovation and integration in the agricultural sector, deeply rooted in its mission to uphold food security and safety. As an integral part of the animal husbandry landscape, CAHI wields a strategic mix of agricultural science and technology, producing a diverse portfolio of products ranging from animal feed to veterinary drugs and vaccines. This vertically integrated approach allows the company to control and optimize each stage of the production process. By doing so, CAHI not only ensures the quality and reliability of its products but also maximizes its operational efficiencies. The company's facilities operate at the forefront of technology, leveraging advancements to develop solutions that boost livestock health and farmer productivity, addressing the growing food demand in China and internationally. Revenue streams for CAHI are robust, stemming from its diversified product lineup designed to cater to the entire spectrum of the animal farming industry. The company monetizes its expertise through the sale of feed additives, veterinary pharmaceuticals, and biological products, which are crucial inputs for livestock farmers aiming to enhance productivity and safeguard their herds against diseases. Beyond just selling products, CAHI's value proposition includes extensive after-sales services and technical support, differentiating itself from competitors. By continuously investing in research and development, CAHI sustains its growth trajectory, adapting to regulatory shifts and consumer preferences while positioning itself as a leader in the global market for animal husbandry solutions. This combination of innovation, integration, and customer-focused services anchors CAHI's business model and drives its profitability.
See Also
What is China Animal Husbandry Industry Co Ltd's EPS (Diluted)?
EPS (Diluted)
0.2
CNY
Based on the financial report for Sep 30, 2025, China Animal Husbandry Industry Co Ltd's EPS (Diluted) amounts to 0.2 CNY.
What is China Animal Husbandry Industry Co Ltd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
-3%
Over the last year, the EPS (Diluted) growth was 133%. The average annual EPS (Diluted) growth rates for China Animal Husbandry Industry Co Ltd have been -22% over the past three years , -15% over the past five years , and -3% over the past ten years .